Ole Andreas Halvorsen
Viking Global Investors
Ole Andreas Halvorsen Laboratory Corp of America Holdings stake
total: 670
Viking Global Investors LH trades
- Total transactions:
- 12
- New positions:
- 2
- Sold out:
- 2
- Added:
- 3
- Reduced:
- 5
- Held since:
- 2020 Q3
- Held for:
- 7 quarters
- Latest activity:
- 2022 Q2
According to 2026 Q2 report, Ole Andreas Halvorsen doesn't hold any Laboratory Corp of America Holdings (LH) shares. To date, the estimated cost basis is nearly $244.19 for "buy" trades and estimated average "sell" price is $258.11. Viking Global Investors first purchased LH in 2015 Q3, initially acquiring about 5.05M shares. Ole Andreas Halvorsen later completely sold out the position and invested in Laboratory Corp of America Holdings again in 2020 Q3. Since the initial investment in Laboratory Corp of America Holdings (LH), Viking Global Investors has made 11 more transactions.
When did Ole Andreas Halvorsen sell Laboratory Corp of America Holdings (LH)?
Ole Andreas Halvorsen sold off the entire Laboratory Corp of America Holdings (LH) position in 2022 Q2.
When did Ole Andreas Halvorsen buy Laboratory Corp of America Holdings (LH)?
Ole Andreas Halvorsen first invested in Laboratory Corp of America Holdings (LH) in 2015 Q3 at the reported quarter-end price of $108.47 per share.
What's the cost basis of Viking Global Investors's LH stake?
The estimated cost basis for Laboratory Corp of America Holdings (LH) stake is around $244.19 per share. This represents their average reported price* across all buy transactions
Estimated cost basis*
- Weighted AVG buy price:
- $244.19
- Weighted AVG sell price:
- $258.11
Ole Andreas Halvorsen's historical trades in Laboratory Corp of America Holdings
12 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2022 Q2
|
0.00%
|
0
|
$263.66
|
|
-100% (-727,287)
|
-0.78%
|
|
2022 Q1
|
0.78%
|
727,287
|
$263.66
|
$191,756,000
|
-14.45% (-122,860)
|
-0.09%
|
|
2021 Q4
|
0.77%
|
850,147
|
$314.21
|
$267,125,000
|
+7.38% (+58,401)
|
+0.05%
|
|
2021 Q3
|
0.61%
|
791,746
|
$281.44
|
$222,829,000
|
-42.35% (-581,668)
|
-0.5%
|
|
2021 Q2
|
1.15%
|
1,373,414
|
$275.85
|
$378,856,000
|
+27.02% (+292,195)
|
+0.24%
|
|
2021 Q1
|
0.82%
|
1,081,219
|
$255.03
|
$275,743,000
|
+1,044.15% (+986,719)
|
+0.75%
|
|
2020 Q4
|
0.05%
|
$203.54
|
-78.01% (-335,280)
|
|||
|
2020 Q3
|
0.29%
|
$188.27
|
new
|
|||
|
2016 Q2
|
0.00%
|
$117.13
|
-100% (-673,048)
|
|||
|
2016 Q1
|
0.35%
|
$117.13
|
-79.02% (-2,535,660)
|
|||
|
2015 Q4
|
1.50%
|
$123.64
|
-36.50% (-1,844,641)
|
|||
|
2015 Q3
|
2.10%
|
$108.47
|
new
|
|||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.